Editas Medicine (EDIT) Reports In-Line Q3 EPS

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.75), in-line with the analyst estimate of ($0.75).

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• MGM Resorts (MGM) PT Raised to $55 at Argus
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)